Arab Finance: A block-trading transaction has been carried out on 48.139 million shares of Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA) at a value of EGP 144.418 million, the Egyptian Exchange (EGX) announced on September 14^th.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms.

Misr For Central Clearing sets refunding date for money spared under account of Rameda's IPO Updated 12/5/2019 12:09:44 PM

Rameda's profits drop to EGP 31M ending Sept. 2019 Updated 12/4/2019 4:50:57 PM

Rameda Pharmaceutical's share placement covered 1.17 times Updated 12/4/2019 5:04:00 PM

FRA nods to Rameda Pharmaceutical to publish IPO prospectus Updated 11/27/2019 12:48:00 PM